Key Facts about Island Pharmaceuticals Limited (ASX: $ILA) Reinstatement to Quotation

Island Pharmaceuticals Limited (ASX: $ILA) has announced the immediate reinstatement to quotation of its options by ASX Compliance on 2 April 2024.

Executive Commentary on Reinstatement to Quotation

We are pleased to announce the reinstatement to quotation of our options by ASX Compliance. This reinstatement reflects our commitment to transparency and compliance with regulatory requirements. We believe that this decision will provide our stakeholders with increased confidence in our securities and demonstrate our dedication to upholding the highest standards of corporate governance.

Summary of Island Pharmaceuticals Limited (ASX: $ILA) Reinstatement to Quotation

Island Pharmaceuticals Limited (ASX: $ILA) has reinstated its options to quotation following the decision by ASX Compliance. The reinstatement underscores the company's adherence to regulatory standards and commitment to transparency. This move is expected to enhance stakeholder confidence in the company's securities. Looking ahead, Island Pharmaceuticals remains focused on maintaining robust corporate governance practices and meeting its regulatory obligations.